Stay Updated

Be among the first to get news and information about FEIBA® [Anti-Inhibitor Coagulant Complex] and hemophilia A or B with inhibitors. Sign up and we'll provide you with the latest from Takeda.

All fields are required unless marked optional.


Personal
Information:

Supporter Information:
Type of Bleeding Disorder:
Specialty:

CHILD'S INFORMATION

Type of Bleeding Disorder:

SECOND CHILD'S INFORMATION

Type of Bleeding Disorder:

 

Additional
Questions:

Answering the following questions will allow us to send
materials that better match your interests.

1. Name of Treatment (Optional) :
Other :

Confirm & Submit:

 
See LessMore

What is FEIBA?

FEIBA is an Anti-Inhibitor Coagulant Complex approved for use in hemophilia A and B patients with inhibitors for:

  • Control and prevention of bleeding episodes

Detailed Important Risk Information

What is FEIBA?

FEIBA is an Anti-Inhibitor Coagulant Complex approved for use in hemophilia A and B patients with inhibitors for:

  • Control and prevention of bleeding episodes
  • Use around the time of surgery
  • Routine prophylaxis to prevent or reduce the frequency of bleeding episodes

Detailed Important Risk Information

  • Blood clots that block blood vessels and their effects have been reported during post-marketing surveillance following infusion of FEIBA, particularly following administration of high doses (above 200 units per kg per day) and/or in patients at risk for forming blood clots.
  • If you experience any of these side effects, call your doctor right away.